Global antimicrobial susceptibility testing market is estimated to be valued at USD 3.94 Bn in 2024, and is expected to exhibit a CAGR of 6.7% during the forecast period (2024-2031). The global antimicrobial susceptibility testing market is projected to witness significant growth from 2023 to 2030. This is mainly due to the rising prevalence of infectious diseases worldwide and increasing need to identify appropriate antibiotic treatments. As per recent studies, at least 2 million people in the U.S. acquire antibiotic-resistant infections every year, leading to over 23,000 deaths. This has boosted the demand for effective antimicrobial susceptibility testing which provides critical information on antibiotic sensitivity that helps clinicians select suitable treatment options. Furthermore, technological advancements in susceptibility testing techniques, such as automation and integration of artificial intelligence, have made the process faster and easier, which is expected to drive the market growth during the forecast period

Market Dynamics:

The global antimicrobial susceptibility testing market is primarily driven by the growing burden of antibiotic-resistant microbial infections and need for rapid and accurate antimicrobial susceptibility testing methods to determine the most effective antimicrobial agents. Some key market drivers include rising prevalence of hospital-acquired infections, increase in new product launches with enhanced capabilities, and initiatives by governments and health agencies to promote antimicrobial stewardship practices. However, the market growth can be challenged by factors such as lengthy approval process for new AST systems, high costs associated with fully-automated systems, and inaccuracies related to manual testing methods. Major opportunities in the market include development of rapid AST platforms with high throughput capabilities, increasing adoption in developing nations, and integration of molecular diagnostic techniques with AST.

Key Features of the Study:

• This report provides an in-depth analysis of the global antimicrobial susceptibility testing market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global antimicrobial susceptibility testing market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this includes Thermo Fisher Scientific Inc., BIOMÉRIEUX, HiMedia Laboratories, Alifax S.r.l., Creative Diagnostics, Resistell AG, Danaher, BD, Merck KGaA, Bio-Rad Laboratories, Inc., Bruker, Nissui Pharmaceutical Co., Ltd., Accelerate Diagnostics, Inc., Zhuhai DL Biotech Co., Ltd., ELITechGroup, Sysmex Corporation, Copan Diagnostics Inc., and Qualigen Therapeutics, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global antimicrobial susceptibility testing market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antimicrobial susceptibility testing market.

Detailed Segmentation-

• By Product Type:
  • Manual Antimicrobial Susceptibility Testing Products
    • Susceptibility Testing Disks
    • Mic Strips
    • Susceptibility Plates
  • Automated Laboratory Instruments
  • Consumables
• By Application:
  • Antibacterial
  • Antifungal
  • Anti-parasitic
  • Antiviral
• By Method:
  • Disk Diffusion
  • Rapid Automated AST
  • Broth Dilution
  • Gradient Diffusion
  • Genotypic Methods
• By End User:
  • Hospitals
  • Pathology/Diagnostic Laboratories
  • Research and Academic Institutes
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa

Company Profiles:

• Thermo Fisher Scientific Inc.
• BIOMÉRIEUX
• HiMedia Laboratories
• Alifax S.r.l.
• Creative Diagnostics
• Resistell AG
• Danaher
• BD
• Merck KGaA
• Bio-Rad Laboratories, Inc.
• Bruker
• Nissui Pharmaceutical Co., Ltd.
• Accelerate Diagnostics, Inc.
• Zhuhai DL Biotech Co., Ltd.
• ELITechGroup
• Sysmex Corporation
• Copan Diagnostics Inc.
• Qualigen Therapeutics, Inc.